Categories
All News

Infusion Pump Software Market Opportunities, Size, Top Manufacturers – Baxter International Inc. (US), Fresenius Kabi (Germany), ICU Medical, Inc. (US), Medtronic plc (Ireland)

Infusion Pump Software Market by Type (DERS, Interoperability, Clinical Workflow), Indication (General Infusion, Pain & Anesthesia Management, Insulin Infusion), End-User (Hospitals, Ambulatory Care Settings) – Global Forecasts to 2024

Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=2097903

The global infusion pumps market is projected to reach USD 18.9 billion by 2025 from USD 13.5 billion in 2020, at a CAGR of 7.0% during the forecast period. The increasing incidence of chronic diseases along with the rapid growth of the geriatric population, rising demand for ambulatory infusion pumps, and the growing volume of surgical procedures performed across the globe are some of the key factors driving the growth of the infusion pumps market.

Infusion Pump Software Market report performs a study of the industry precisely which explains what the market definition, classifications, applications, engagements, and global industry trends are. This market research report is a great option to make better decisions, generate maximum revenue, and enhance business profit. In this competitive age, comprehensive knowledge about the competitive landscape, the product range of the competitors, strategies, and future prospects are very important. Additionally, this Infusion Pump Software Market business research report combines historic data, current market trends, market environment, technological innovation, upcoming technologies, and the technical progress in the related industry.

The leading players in this market include Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), Baxter International Inc. (US), Fresenius Kabi (Germany), ICU Medical, Inc. (US), Medtronic plc (Ireland), Moog Inc. (US), Smiths Medical (US), Terumo Corporation (Japan), NIPRO Corporation (Japan), Avanos Medical, Inc. (US), Tandem Diabetes Care, Inc. (US), JMS Co., Ltd. (Japan), Insulet Corporation (US), Roche Diagnostics (Switzerland), Zyno Medical (US), Teleflex, Inc. (US), Mindray Medical International Limited (China), Micrel Medical Devices SA (Greece), and Ypsomed Holding AG (Switzerland).

“In 2019, the chemotherapy/oncology segment accounted for the largest share of the market.”

On the basis of application, the chemotherapy/oncology segment accounted for the largest share of the infusion pumps market in 2019. The large share of this segment can be attributed to the growing incidence of cancer, increasing availability of ambulatory infusion pumps for chemotherapy, and the introduction of technologically advanced products in the market.

“In 2019, the hospitals’ segment accounted for the largest share of the market.”

On the basis of end users, the hospitals’ segment accounted for the largest share of the infusion pumps market in 2019. The large share of this segment is attributed to the strong financial capabilities of hospitals for purchasing high-priced infusion devices, the large patient pool treated at hospitals, and the availability of trained professionals to operate infusion pumps.

“APAC is projected to witness the highest growth during the forecast period.”

The APAC market is estimated to register the highest CAGR during the forecast period. Factors such as the rising geriatric population, growing incidence of chronic diseases, increased accessibility to advanced healthcare facilities, rising healthcare spending, rapidly improving health insurance sector, growing demand for advanced technologies, and the expansion of private-sector hospitals to rural areas is fueling the demand for infusion pumps in the APAC region.

The breakdown of primary participants was as mentioned below:

  • By Company Type: Tier 1–40%, Tier 2–35%, and Tier 3–25%
  • By Designation: C-level–25%, Director Level–55%, and Others–20%
  • By Region: North America–40%, Europe–25%, Asia Pacific–20%,Latin America–10%, Middle East & Africa–5%

Research Coverage:

The report analyzes the various infusion pump devices and their adoption patterns. It aims at estimating the market size and future growth potential of the infusion pumps market for different segments such as product, application,end user,and region. The report also includes an in-depth competitive analysis of the key players in this market, along with their company profiles, product offerings, and recent developments.

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a greater share. Firms purchasing the report could use one or any combination of the below-mentioned five strategies for strengthening the market.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the infusion pumps market
  • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities,and product launches in the infusion pumps market
  • Market Development: Comprehensive information on the lucrative emerging regions by product, application, end user, and region
  • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the infusion pumps market
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and products of leading players in the infusion pumps market

For More Information or Query or Customization Before Buying, Visit @ https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=2097903

Table of Contents

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Markets Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Secondary Sources
2.1.2 Primary Data
2.1.3 Primary Sources
2.1.3.1 Key Insights From Primary Sources
2.1.3.2 Market Size Estimation Methodology
2.1.4 Market Data Estimation and Triangulation
2.2 Assumptions

3 Executive Summary

4 Premium Insights
4.1 Infusion Pump Software Market Overview
4.2 Geographic Analysis: European Infusion Pump Software Market Share, By Type, 2019
4.3 Infusion Pump Software Market Share, By Indication, 2019 vs. 2024
4.4 Infusion Pump Software Market Share, By Type, 2019 vs. 2024
4.5 Infusion Pump Software Market Share, By End User, 2019 vs. 2024
4.6 Infusion Pump Software Market: Geographical Snapshot

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Market Drivers
5.2.1.1 Increasing Incidence of Chronic Diseases and Rapid Growth in Geriatric Population
5.2.1.2 Growing Number of Surgical Procedures Performed
5.2.1.3 Rising Demand for Ambulatory and Home Care Infusion Pumps
5.2.1.4 Technological Developments
5.2.2 Market Restraints
5.2.2.1 Frequent Product Recalls of Infusion Pumps
5.2.3 Market Opportunities
5.2.3.1 Untapped Emerging Markets
5.2.3.2 Growing Adoption of Specialty Infusion Systems
5.2.4 Challenges
5.2.4.1 Increasing Incidence of Medication Errors and Lack of Wireless Connectivity in Most Hospitals

6 Infusion Pump Software Market, By Type
6.1 Introduction
6.2 Dose Error Reduction Software (DERS)
6.2.1 Increasing Incidence of Medication Errors is Driving the Demand for DERS in Infusion Pumps
6.3 Clinical Workflow Software
6.3.1 Clinical Workflow Software Enables Automation of the Entire Process of A Patient’s Assessment and Treatment
6.4 Interoperability Software
6.4.1 Interoperability Software Helps in Reducing Manual Programming Errors
6.5 Others

7 Infusion Pump Software Market, By Indication
7.1 Introduction
7.2 General Infusion
7.2.1 Availability of Safer and Efficient Infusion Pumps to Propel the Market for General Infusion
7.3 Pain & Anesthesia Management
7.3.1 High Incidence of Chronic Pain Will Drive the Market for Pain Management
7.4 Insulin Infusion
7.4.1 Significant Increase in the Global Prevalence of Diabetes Will Drive Market Growth
7.5 Chemotherapy
7.5.1 Demand for Controlled and Targeted Delivery of Medication to Drive the Chemotherapy Market
7.6 Enteral Infusion
7.6.1 Infusion Pumps Facilitate Continuous and Controlled Parenteral Flow
7.7 Other Indications

8 Infusion Pump Software Market, By End User
8.1 Introduction
8.2 Hospitals
8.2.1 Hospitals Dominate the Infusion Pump Software Market, By End User
8.3 Ambulatory Care Settings
8.3.1 Need to Reduce Healthcare Expenditure has Boosted the Preference for Ambulatory Care
8.4 Home Care Settings
8.4.1 Rising Acceptance and Cost-Efficiency of Home Care Products Have Driven their Use
8.5 Academic & Research Institutes
8.5.1 Rising Drug Discovery Activity and Incidence of Medication Errors is Driving Market Growth

9 Infusion Pump Software Market, By Region
9.1 Introduction
9.2 North America
9.2.1 US
9.2.1.1 US is the Largest Market for Infusion Pump Software
9.2.2 Canada
9.2.2.1 Favorable Reimbursement Scenario for Infusion Pumps to Propel the Market in Canada
9.3 Europe
9.3.1 Germany
9.3.1.1 Germany is the Fastest-Growing Market for Infusion Pump Software in Europe
9.3.2 France
9.3.2.1 The Healthcare System in France is Among the Best in the World
9.3.3 UK
9.3.3.1 High Number of Medication Errors in the UK to Drive Market Growth
9.3.4 RoE
9.4 APAC
9.4.1 China
9.4.1.1 Growing Investments in Healthcare Infrastructure to Support Market Growth
9.4.2 Japan
9.4.2.1 Rapid Growth in the Geriatric Population and the Rising Prevalence of Age-Related Illnesses to Drive Market Growth
9.4.3 India
9.4.3.1 High Prevalence of Lifestyle Diseases to Drive the Market for Infusion Pump Software
9.4.4 RoAPAC
9.5 Rest of the World

10 Competitive Landscape
10.1 Overview
10.1.1 Market Ranking of Players, 2018
10.2 Competitive Leadership Mapping
10.2.1 Visionary Leaders
10.2.2 Innovators
10.2.3 Dynamic Differentiators
10.2.4 Emerging Companies
10.3 Competitive Scenario
10.3.1 Product Launches
10.3.2 Expansions
10.3.3 Partnerships, Agreements, and Collaborations
10.3.4 Acquisitions

11 Company Profiles
11.1 Becton, Dickinson and Company (BD)
11.2 B. Braun Melsungen AG (B. Braun)
11.3 Baxter International Inc. (Baxter)
11.4 Fresenius Kabi
11.5 ICU Medical, Inc. (ICU Medical)
11.6 Medtronic Plc (Medtronic)
11.7 Moog Inc. (Moog)
11.8 Smiths Medical (A Division of Smiths Group Plc)
11.9 Terumo Corporation
11.10 Roche Diagnostics (A Division of F. Hoffmann- La Roche Ltd.)
11.11 Ypsomed AG (Ypsomed)
11.12 Micrel Medical Devices

12 Appendix
12.1 Discussion Guide
12.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
12.3 Available Customizations
12.4 Related Reports
12.5 Author Details

Purchase the Report Directly @ https://www.reportsnreports.com/purchase.aspx?name=2097903

https://bisouv.com/